4//SEC Filing
KAY CHRISTINA 4
Accession 0001064901-22-000001
CIK 0001016504other
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 6:53 PM ET
Size
5.7 KB
Accession
0001064901-22-000001
Insider Transaction Report
Form 4
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
- Award
Stock Option (right to buy)
2022-11-09+100,000→ 100,000 totalExp: 2032-11-09→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission.
- [F2]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001064901
Filing Metadata
- Form type
- 4
- Filed
- Nov 9, 7:00 PM ET
- Accepted
- Nov 10, 6:53 PM ET
- Size
- 5.7 KB